Cancer Research AACR Membership Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Okegawa, T.
Right arrow Articles by Hsieh, J.-T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Okegawa, T.
Right arrow Articles by Hsieh, J.-T.
[Cancer Research 61, 6592-6600, September 1, 2001]
© 2001 American Association for Cancer Research

Tumor Biology

The Mechanism of the Growth-inhibitory Effect of Coxsackie and Adenovirus Receptor (CAR) on Human Bladder Cancer: A Functional Analysis of CAR Protein Structure1

Takatsugu Okegawa, Rey-Chen Pong, Yingming Li, Jeffrey M. Bergelson, Arthur I. Sagalowsky and Jer-Tsong Hsieh2

Department of Urology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390 [T. O., R-C. P., Y. L., A. I. S., J-T. H.], and Division of Immunologic and Infectious Diseases, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania 19104 [J. M. B.]

The coxsackie and adenovirus receptor (CAR) is identified as a high-affinityreceptor for adenovirus type 5. We observed that invasive bladder cancer specimens had significantly reduced CAR mRNA levels compared with superficial bladder cancer specimens, which suggests that CAR may play a role in the progression of bladder cancer. Elevated CAR expression in the T24 cell line (CAR-negative cells) increased its sensitivity to adenovirus infection and significantly inhibited its in vitro growth, accompanied by p21 and hypophosphorylated retinoblastoma accumulation. Conversely, decreased CAR levels in both RT4 and 253J cell lines (CAR-positive cells) promoted their in vitro growth. To unveil the mechanism of action of CAR, we showed that the extracellular domain of CAR facilitated intercellular adhesion. Furthermore, interrupting intercellular adhesion of CAR by a specific antibody alleviates the growth-inhibitory effect of CAR. We also demonstrated that both the transmembrane and intracellular domains of CAR were critical for its growth-inhibitory activity. These data indicate that the cell-cell contact initiated by membrane-bound CAR can elicit a negative signal cascade to modulate cell cycle regulators inside the nucleus of bladder cancer cells. Therefore, the presence of CAR cannot only facilitate viral uptake of adenovirus but also inhibit cell growth. These results can be integrated to formulate a new strategy for bladder cancer therapy.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
C.-C. Chang, G.-S. Shieh, P. Wu, C.-C. Lin, A.-L. Shiau, and C.-L. Wu
Oct-3/4 Expression Reflects Tumor Progression and Regulates Motility of Bladder Cancer Cells
Cancer Res., August 1, 2008; 68(15): 6281 - 6291.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
E. J. Chapman, G. Kelly, and M. A. Knowles
Genes Involved in Differentiation, Stem Cell Renewal, and Tumorigenesis Are Modulated in Telomerase-Immortalized Human Urothelial Cells
Mol. Cancer Res., July 1, 2008; 6(7): 1154 - 1168.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
K. Guse, T. Ranki, M. Ala-Opas, P. Bono, M. Sarkioja, M. Rajecki, A. Kanerva, T. Hakkarainen, and A. Hemminki
Treatment of metastatic renal cancer with capsid-modified oncolytic adenoviruses
Mol. Cancer Ther., October 1, 2007; 6(10): 2728 - 2736.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H.-J. Li, M. Everts, L. Pereboeva, S. Komarova, A. Idan, D. T. Curiel, and H. R. Herschman
Adenovirus Tumor Targeting and Hepatic Untargeting by a Coxsackie/Adenovirus Receptor Ectodomain Anti-Carcinoembryonic Antigen Bispecific Adapter
Cancer Res., June 1, 2007; 67(11): 5354 - 5361.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. T. Fok, K.-C. Huang, P. C. Holland, and J. Nalbantoglu
The Coxsackie and Adenovirus Receptor Binds Microtubules and Plays a Role in Cell Migration
J. Biol. Chem., March 9, 2007; 282(10): 7512 - 7521.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
M. E. Goldsmith, A. Aguila, K. Steadman, A. Martinez, S. M. Steinberg, M. C. Alley, W. R. Waud, S. E. Bates, and T. Fojo
The histone deacetylase inhibitor FK228 given prior to adenovirus infection can boost infection in melanoma xenograft model systems
Mol. Cancer Ther., February 1, 2007; 6(2): 496 - 505.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
C.-L. Chen, J. Sung, M. Cohen, W. H. Chowdhury, M. D. Sachs, Y. Li, Y. Lakshmanan, B. Y. M. Yung, S. E. Lupold, and R. Rodriguez
Valproic Acid Inhibits Invasiveness in Bladder Cancer but Not in Prostate Cancer Cells
J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 533 - 542.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R.-C. Pong, R. Roark, J.-Y. Ou, J. Fan, J. Stanfield, E. Frenkel, A. Sagalowsky, and J.-T. Hsieh
Mechanism of Increased Coxsackie and Adenovirus Receptor Gene Expression and Adenovirus Uptake by Phytoestrogen and Histone Deacetylase Inhibitor in Human Bladder Cancer Cells and the Potential Clinical Application.
Cancer Res., September 1, 2006; 66(17): 8822 - 8828.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
J.-W. Chen, B. Zhou, Q.-C. Yu, S. J. Shin, K. Jiao, M. D. Schneider, H. S. Baldwin, and J. M. Bergelson
Cardiomyocyte-Specific Deletion of the Coxsackievirus and Adenovirus Receptor Results in Hyperplasia of the Embryonic Left Ventricle and Abnormalities of Sinuatrial Valves
Circ. Res., April 14, 2006; 98(7): 923 - 930.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. K. Earel Jr., R. L. VanOosten, and T. S. Griffith
Histone Deacetylase Inhibitors Modulate the Sensitivity of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Resistant Bladder Tumor Cells
Cancer Res., January 1, 2006; 66(1): 499 - 507.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
Y. Zhang and J. M. Bergelson
Adenovirus Receptors
J. Virol., October 1, 2005; 79(19): 12125 - 12131.
[Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
D. R. Asher, A. M. Cerny, and R. W. Finberg
The erythrocyte viral trap: Transgenic expression of viral receptor on erythrocytes attenuates coxsackievirus B infection
PNAS, September 6, 2005; 102(36): 12897 - 12902.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
A. A. Dorner, F. Wegmann, S. Butz, K. Wolburg-Buchholz, H. Wolburg, A. Mack, I. Nasdala, B. August, J. Westermann, F. G. Rathjen, et al.
Coxsackievirus-adenovirus receptor (CAR) is essential for early embryonic cardiac development
J. Cell Sci., August 1, 2005; 118(15): 3509 - 3521.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Bruning, E. Stickeler, D. Diederich, L. Walz, H. Rohleder, K. Friese, and I. B. Runnebaum
Coxsackie and Adenovirus Receptor Promotes Adenocarcinoma Cell Survival and Is Expressionally Activated after Transition from Preneoplastic Precursor Lesions to Invasive Adenocarcinomas
Clin. Cancer Res., June 15, 2005; 11(12): 4316 - 4320.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. C.A. Graat, P. I.J.M. Wuisman, V. W. van Beusechem, J. E. Carette, W. R. Gerritsen, J. Bras, G. R. Schaap, G. J.L. Kaspers, A. Ogose, W. Gu, et al.
Coxsackievirus and Adenovirus Receptor Expression on Primary Osteosarcoma Specimens and Implications for Gene Therapy with Recombinant Adenoviruses
Clin. Cancer Res., March 15, 2005; 11(6): 2445 - 2448.
[Full Text] [PDF]

Home page
 J. Virol.Home page
F. Kuhnel, B. Schulte, T. Wirth, N. Woller, S. Schafers, L. Zender, M. Manns, and S. Kubicka
Protein Transduction Domains Fused to Virus Receptors Improve Cellular Virus Uptake and Enhance Oncolysis by Tumor-Specific Replicating Vectors
J. Virol., December 15, 2004; 78(24): 13743 - 13754.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. B. Coyne, T. Voelker, S. L. Pichla, and J. M. Bergelson
The Coxsackievirus and Adenovirus Receptor Interacts with the Multi-PDZ Domain Protein-1 (MUPP-1) within the Tight Junction
J. Biol. Chem., November 12, 2004; 279(46): 48079 - 48084.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
V. Armbruester, M. Sauter, K. Roemer, B. Best, S. Hahn, A. Nty, A. Schmid, S. Philipp, A. Mueller, and N. Mueller-Lantzsch
Np9 Protein of Human Endogenous Retrovirus K Interacts with Ligand of Numb Protein X
J. Virol., October 1, 2004; 78(19): 10310 - 10319.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Qin, B. Escuadro, M. Dohadwala, S. Sharma, and R. K. Batra
A Novel Role for the Coxsackie Adenovirus Receptor in Mediating Tumor Formation by Lung Cancer Cells
Cancer Res., September 15, 2004; 64(18): 6377 - 6380.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
J. Skog, K. Edlund, B. Widegren, L. G. Salford, G. Wadell, and Y.-F. Mei
Efficient internalization into low-passage glioma cell lines using adenoviruses other than type 5: an approach for improvement of gene delivery to brain tumours
J. Gen. Virol., September 1, 2004; 85(9): 2627 - 2638.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
K. J. D. A. Excoffon, A. Hruska-Hageman, M. Klotz, G. L. Traver, and J. Zabner
A role for the PDZ-binding domain of the coxsackie B virus and adenovirus receptor (CAR) in cell adhesion and growth
J. Cell Sci., September 1, 2004; 117(19): 4401 - 4409.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Dorner, D. Xiong, K. Couch, T. Yajima, and K. U. Knowlton
Alternatively Spliced Soluble Coxsackie-adenovirus Receptors Inhibit Coxsackievirus Infection
J. Biol. Chem., April 30, 2004; 279(18): 18497 - 18503.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R.-C. Pong, Y.-J. Lai, H. Chen, T. Okegawa, E. Frenkel, A. Sagalowsky, and J.-T. Hsieh
Epigenetic Regulation of Coxsackie and Adenovirus Receptor (CAR) Gene Promoter in Urogenital Cancer Cells
Cancer Res., December 15, 2003; 63(24): 8680 - 8686.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. E. Goldsmith, M. Kitazono, P. Fok, T. Aikou, S. Bates, and T. Fojo
The Histone Deacetylase Inhibitor FK228 Preferentially Enhances Adenovirus Transgene Expression in Malignant Cells
Clin. Cancer Res., November 1, 2003; 9(14): 5394 - 5401.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
A. Yacoub, C. Mitchell, J. Brannon, E. Rosenberg, L. Qiao, R. McKinstry, W. M. Linehan, Z.-s. Su, D. Sarkar, I. V. Lebedeva, et al.
MDA-7 (Interleukin-24) Inhibits the Proliferation of Renal Carcinoma Cells and Interacts with Free Radicals to Promote Cell Death and Loss of Reproductive Capacity
Mol. Cancer Ther., July 1, 2003; 2(7): 623 - 632.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
L. C. Pagliaro, A. Keyhani, D. Williams, D. Woods, B. Liu, P. Perrotte, J. W. Slaton, J. A. Merritt, H. B. Grossman, and C. P. Dinney
Repeated Intravesical Instillations of an Adenoviral Vector in Patients With Locally Advanced Bladder Cancer: A Phase I Study of p53 Gene Therapy
J. Clin. Oncol., June 15, 2003; 21(12): 2247 - 2253.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Anders, R. Hansen, R.-X. Ding, K. A. Rauen, M. J. Bissell, and W. M. Korn
Disruption of 3D tissue integrity facilitates adenovirus infection by deregulating the coxsackievirus and adenovirus receptor
PNAS, February 18, 2003; 100(4): 1943 - 1948.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
H. Fechner, M. Noutsias, C. Tschoepe, K. Hinze, X. Wang, F. Escher, M. Pauschinger, D. Dekkers, R. Vetter, M. Paul, et al.
Induction of Coxsackievirus-Adenovirus-Receptor Expression During Myocardial Tissue Formation and Remodeling: Identification of a Cell-to-Cell Contact-Dependent Regulatory Mechanism
Circulation, February 18, 2003; 107(6): 876 - 882.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Hemminki, A. Kanerva, B. Liu, M. Wang, R. D. Alvarez, G. P. Siegal, and D. T. Curiel
Modulation of Coxsackie-Adenovirus Receptor Expression for Increased Adenoviral Transgene Expression
Cancer Res., February 15, 2003; 63(4): 847 - 853.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. Petrella, C. J. Cohen, J. Gaetz, and J. M. Bergelson
A Zebrafish Coxsackievirus and Adenovirus Receptor Homologue Interacts with Coxsackie B Virus and Adenovirus
J. Virol., September 11, 2002; 76(20): 10503 - 10506.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. S. Haviv, J. L. Blackwell, A. Kanerva, P. Nagi, V. Krasnykh, I. Dmitriev, M. Wang, S. Naito, X. Lei, A. Hemminki, et al.
Adenoviral Gene Therapy for Renal Cancer Requires Retargeting to Alternative Cellular Receptors
Cancer Res., August 1, 2002; 62(15): 4273 - 4281.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
N. Belousova, V. Krendelchtchikova, D. T. Curiel, and V. Krasnykh
Modulation of Adenovirus Vector Tropism via Incorporation of Polypeptide Ligands into the Fiber Protein
J. Virol., July 29, 2002; 76(17): 8621 - 8631.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
A. Hemminki, K. R. Zinn, B. Liu, T. R. Chaudhuri, R. A. Desmond, B. E. Rogers, M. N. Barnes, R. D. Alvarez, and D. T. Curiel
In Vivo Molecular Chemotherapy and Noninvasive Imaging With an Infectivity-Enhanced Adenovirus
J Natl Cancer Inst, May 15, 2002; 94(10): 741 - 749.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
W. van't Hof and R. G. Crystal
Fatty Acid Modification of the Coxsackievirus and Adenovirus Receptor
J. Virol., May 15, 2002; 76(12): 6382 - 6386.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. J. Cohen, J. T. C. Shieh, R. J. Pickles, T. Okegawa, J.-T. Hsieh, and J. M. Bergelson
The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction
PNAS, November 29, 2001; (2001) 261452898.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. J. Cohen, J. T. C. Shieh, R. J. Pickles, T. Okegawa, J.-T. Hsieh, and J. M. Bergelson
The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction
PNAS, December 18, 2001; 98(26): 15191 - 15196.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.